SurGenTec earned FDA 510(k) clearance of its ION-C facet fixation system, according to a Jan. 20 news release.
ION-C is designed for posterior cervical fusion, and the clearance includes indications for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints.
The clearance was built on an IRB-approved study that affirmed the safety and efficacy of ION-C when implanted bilaterally within the facet joints. Long-term outcomes found no adverse events, implant migration or revision surgeries.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
